Evidence-Based Medicine Guidelines
Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Subcutaneous Unfractionated Heparin for the Initial Treatment of Venous Thromboembolism." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/450587/all/Subcutaneous_unfractionated_heparin_for_the_initial_treatment_of_venous_thromboembolism.
Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/450587/all/Subcutaneous_unfractionated_heparin_for_the_initial_treatment_of_venous_thromboembolism. Accessed April 29, 2025.
Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/450587/all/Subcutaneous_unfractionated_heparin_for_the_initial_treatment_of_venous_thromboembolism
Subcutaneous Unfractionated Heparin for the Initial Treatment of Venous Thromboembolism [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 April 29]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/450587/all/Subcutaneous_unfractionated_heparin_for_the_initial_treatment_of_venous_thromboembolism.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism
ID - 450587
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/450587/all/Subcutaneous_unfractionated_heparin_for_the_initial_treatment_of_venous_thromboembolism
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
